-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Of Gains and Losses: SAMD9L Mutations in Myeloid Malignancies

Program: Scientific Workshops @ ASH
Session: SAMD9/SAMD9L Syndrome: Clinical and Biological Aspects
Friday, December 4, 2020, 7:52 AM-8:32 AM

Jörg Cammenga, MD

Linköping University, Linköping, Sweden

Disclosures: No relevant conflicts of interest to declare.

See more of: SAMD9/SAMD9L Syndrome: Clinical and Biological Aspects
See more of: Scientific Workshops @ ASH
<< Previous Presentation | Next Presentation >>